Evidence-Based Complementary and Alternative Medicine [53] P. Liu, Y. C. Ge, T. S. Ma, H. J. Ren, Y. J. Xu, and D. M. Xu, “Eﬀects of the extracts from Decoction for resuscitation and its component herbs on PGI2, TXA2 and NO release from rat vascular endothelial cells under hypoxia in vitro,” Zhongguo Zhongyao Zazhi, vol. 29, no. 10, pp. 988–992, 2004. [54] Z. H. Fan, K. Isobe, K. Kiuchi, and I. Nakashima, “Enhance- ment of nitric oxide production from activated macrophages by a puriﬁed form of ginsenoside (Rg1),” The American journal of Chinese medicine, vol. 23, no. 3-4, pp. 279–287, 1995. [55] W. Z. Wang, A. Matsumori, Y. Matoba et al., “Protective eﬀects of Mu-Fang-Ji-Tang against myocardial injury in a murine model of congestive heart failure induced by viral myocar- ditis,” Life Sciences, vol. 62, no. 13, pp. 1139–1146, 1998. [56] J. Zand, F. Lanza, H. K. Garg, and N. S. Bryan, “All-natural nitrite and nitrate containing dietary supplement promotes nitric oxide production and reduces triglycerides in humans,” Nutrition Research, vol. 31, no. 4, pp. 262–269, 2011. [57] F. F. Y. Lam, J. H. K. Yeung, K. M. Chan, and P. M. Y. Or, “Mechanisms of the dilator action of cryptotanshinone on rat coronary artery,” European Journal of Pharmacology, vol. 578, no. 2-3, pp. 253–260, 2008. [58] F. Y. Lam, S. C. W. Ng, J. H. Y. Cheung, and J. H. K. Yeung, “Mechanisms of the vasorelaxant eﬀect of Danshen (Salvia miltiorrhiza) in rat knee joints,” Journal of Ethnopharmacology, vol. 104, no. 3, pp. 336–344, 2006. [59] L. Zhou, Z. Zuo, and M. S. S. Chow, “Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use,” Journal of Clinical Pharmacology, vol. 45, no. 12, pp. 1345–1359, 2005. [60] M. H. Li, J. M. Chen, Y. Peng, Q. Wu, and P. G. Xiao, “Inves- tigation of Danshen and related medicinal plants in China,” Journal of Ethnopharmacology, vol. 120, no. 3, pp. 419–426, 2008. [61] W. Li, Z. W. Li, J. P. Han, X. X. Li, J. Gao, and C. X. Liu, “Determination and pharmacokinetics of danshensu in rat plasma after oral administration of danshen extract using liquid chromatography/tandem mass spectrometry,” European Journal of Drug Metabolism and Pharmacokinetics, vol. 33, no. 1, pp. 9–16, 2008. [62] Y. H. Li, X. P. Sun, Y. Q. Zhang, and N. S. Wang, “The anti- thrombotic eﬀect of Borneol related to its anticoagulant pro- perty,” American Journal of Chinese Medicine, vol. 36, no. 4, pp. 719–727, 2008. [63] S. Y. Zhang, G. Chen, P. F. Wei et al., “The eﬀect of puerarin on serum nitric oxide concentration and myocardial eNOS expression in rats with myocardial infarction,” Journal of Asian natural products research, vol. 10, no. 3-4, pp. 373–381, 2008. [64] X. D. Li, Y. J. Yang, Y. J. Geng et al., “Tongxinluo reduces myo- cardial no-reﬂow and ischemia-reperfusion injury by stimu- lating the phosphorylation of eNOS via the PKA pathway,” American Journal of Physiology, vol. 299, no. 4, pp. H1255– H1261, 2010. [65] Y. T. Cheng, Y. J. Yang, H. T. Zhang et al., “Pretreatment with Tongxinluo protects porcine myocardium from ischae- mia/reperfusion injury through a nitric oxide related mech- anism,” Chinese Medical Journal, vol. 122, no. 13, pp. 1529– 1538, 2009. [66] C. Pan, L. Lou, Y. Huo et al., “Salvianolic acid B and Tanshi- none IIA attenuate myocardial ischemia injury in mice by no production through multiple pathways,” Therapeutic Advances in Cardiovascular Disease, vol. 5, no. 2, pp. 99–111, 2011. [67] J. Loscalzo, “Oxidative stress in endothelial cell dysfunction and thrombosis,” Pathophysiology of Haemostasis and Throm- bosis, vol. 32, no. 5-6, pp. 359–360, 2002. 9 [68] S. Hasani-Ranjbar, B. Larijani, and M. Abdollahi, “A sys- tematic review of the potential herbal sources of future drugs eﬀective in oxidant-related diseases,” Inﬂammation and Allergy—Drug Targets, vol. 8, no. 1, pp. 2–10, 2009. [69] S. Wang, S. Penchala, S. Prabhu, J. Wang, and Y. Huang, “Mo- lecular basis of traditional chinese medicine in cancer chemo- prevention,” Current Drug Discovery Technologies, vol. 7, no. 1, pp. 67–75, 2010. [70] Q. Chu, K. Hashimoto, K. Satoh, Q. Wang, and H. Sakagami, “Eﬀect of three herbal extracts on NO and PGE2 production by activated mouse macrophage-like cells,” In Vivo, vol. 23, no. 4, pp. 537–544, 2009. [71] B. M. Dietz, D. Liu, G. K. Hagos et al., “Angelica sinensis and its alkylphthalides induce the detoxiﬁcation enzyme NAD(P)H: quinone oxidoreductase 1 by alkylating keap1,” Chemical Research in Toxicology, vol. 21, no. 10, pp. 1939– 1948, 2008. [72] Y. C. Po, Y. L. Hoi, A. H. Y. Siu et al., “Dang-Gui Buxue Tang Protects against oxidant injury by enhancing cellular glutathi- one in H9c2 cells: role of glutathione synthesis and regenera- tion,” Planta Medica, vol. 73, no. 2, pp. 134–141, 2007. [73] W. L. Wu, W. L. Chang, and C. F. Chen, “Cytotoxic activities of tanshinones against human carcinoma cell lines,” American Journal of Chinese Medicine, vol. 19, no. 3-4, pp. 207–216, 1991. [74] R. Yang, A. Liu, X. Ma, L. Li, D. Su, and J. Liu, “Sodium tan- shinone IIA sulfonate protects cardiomyocytes against oxida- tive stress-mediated apoptosis through inhibiting JNK activa- tion,” Journal of Cardiovascular Pharmacology, vol. 51, no. 4, pp. 396–401, 2008. [75] N. Khan and H. Mukhtar, “Multitargeted therapy of cancer by green tea polyphenols,” Cancer Letters, vol. 269, no. 2, pp. 269– 280, 2008.